Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cellular Medicine Association (CMA) is a professional organization and training provider focused on regenerative medicine and cellular therapies in aesthetics and sexual health. Founded by Dr. Charles Runels, the association is the governing body for several trademarked medical procedures, including the Vampire Facelift, O-Shot, and P-Shot, which utilize Platelet-Rich Plasma (PRP) to stimulate tissue rejuvenation. CMA provides medical professionals with standardized clinical protocols, certification, and marketing support to integrate these cash-based treatments into their practices. The organization also sponsors and funds independent clinical research to validate the efficacy of cellular treatments for conditions such as urinary incontinence and lichen sclerosus. By maintaining high standards of training and intellectual property protection, the CMA aims to ensure patient safety and provider success in the field of cellular medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellular Medicine Association.